OR OR Reports Strong Q1 2026 Revenue NA EPS Beats DeutscheBank DB Stock Down 262 Support Test at 2935 20260517 Himalaya HSHP Q4 2025 Results Miss Estimates EPS 029 vs 031 Penske PAG Stock Analysis Falls 152 Watching 15172 20260518 Viatris VTRS Q1 2026 Earnings 059 EPS Surges Past 051 Estimates Paymentus Holdings PAY Q1 2026 Earnings EPS 021 Beats Estimates Peoples PEBK Q4 2025 Earnings Stay the Course EPS 121 US Payrolls Exceed Expectations in April But Report Signals Economic Caution Egypts Landmark Gas Discoveries Signal Upstream Revival Yet Import Challenges Remain QXO Launches Hostile Bid for Beacon After Repeated Rejections T1 Energy Stock Surges 42 on Analyst Bullish Call Amid ShortSeller Allegations Traders Shift Rate Expectations Feds Next Move Could Be a Hike as Soon as December US Stocks Edge Higher as Chip Rally Continues Micron Surges 9 on AI Optimism Meta Shares Decline Following Quarterly Results Iran Internet Disruptions Weigh on User Growth PubMatic PUBM Q1 2026 Earnings EPS Beats Estimates as AdTech Efficiency Drives Positive Surprise NTNX Q1 2026 Earnings Strong EPS Beat Drives Stock Surge PTON Q1 2026 Earnings EPS Misses Estimates as Cost Initiatives Gain Traction BWFG Q1 2026 Earnings EPS Beats Estimates by 13 Amid Solid Operating Performance BrightView Holdings BV Q1 2026 Earnings EPS Misses Estimates Amid Strategic Execution Potential TwoDay Strike Could Disrupt State Bank of India Branch Services on May 2526 Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage TDY Q1 2026 Earnings Earnings Beat Estimates Stock Rises Chime Financial Inc CHYM Q1 2026 Earnings Robust EPS Beat Defies Market Skepticism Electra Battery Materials Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Company Advances Battery Materials Projects FormFactor FORM Q1 2026 Earnings EPS Surges Past Estimates Stock Rises SHIM Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement NEON Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase